PROPHYLAXIS OF NON BLEEDING GASTRIC VARICES.

PROPHYLACTIC CYANOACRYLATE INJECTION FOR GASTRIC EXTENSION OF ESOPHAGEAL VARICES TYPE II: A RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202008491799224

Enrollment

Registered

2020-08-27

Start date

2018-10-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System

Interventions

Endoscopic Cyanoacrylate injection of gastric variceal extension type II

Esophageal variceal band ligation and Carvedilol

Endoscopic esophageal variceal band ligation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All cirrhotic patients who will present with healthy non bleeding gastric varices associated with bleeding or high risky esophageal varices will be included in the study.

Exclusion criteria

Exclusion criteria: - Patient who refused to be enrolled in our study. Patients with active or previously bled from gastric varices. or have - Impending to bleed gastric varices - Patients who have any contraindication to beta blockers.

Design outcomes

Primary

Measure	Time frame
GI bleeding	—

Secondary

Measure	Time frame
Changes in size or risk of gastric varices;Changes in portal hypertensive gastropathy;Mortality	—

Countries

Egypt

Contacts

Public ContactSamer Fathy

Office director

samerfathi2012@gmail.com00201065264003

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026